122 related articles for article (PubMed ID: 12126757)
1. A novel iron chelator that does not induce HIF-1 activity.
Creighton-Gutteridge M; Tyrrell RM
Free Radic Biol Med; 2002 Aug; 33(3):356-63. PubMed ID: 12126757
[TBL] [Abstract][Full Text] [Related]
2. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation.
Bianchi L; Tacchini L; Cairo G
Nucleic Acids Res; 1999 Nov; 27(21):4223-7. PubMed ID: 10518614
[TBL] [Abstract][Full Text] [Related]
3. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin.
Zaman K; Ryu H; Hall D; O'Donovan K; Lin KI; Miller MP; Marquis JC; Baraban JM; Semenza GL; Ratan RR
J Neurosci; 1999 Nov; 19(22):9821-30. PubMed ID: 10559391
[TBL] [Abstract][Full Text] [Related]
4. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity.
Agani F; Semenza GL
Mol Pharmacol; 1998 Nov; 54(5):749-54. PubMed ID: 9804609
[TBL] [Abstract][Full Text] [Related]
5. Prooxidant and antioxidant properties of salicylaldehyde isonicotinoyl hydrazone iron chelators in HepG2 cells.
Caro AA; Commissariat A; Dunn C; Kim H; García SL; Smith A; Strang H; Stuppy J; Desrochers LP; Goodwin TE
Biochim Biophys Acta; 2015 Nov; 1850(11):2256-64. PubMed ID: 26275495
[TBL] [Abstract][Full Text] [Related]
6. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes.
Horackova M; Ponka P; Byczko Z
Cardiovasc Res; 2000 Aug; 47(3):529-36. PubMed ID: 10963725
[TBL] [Abstract][Full Text] [Related]
7. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
[TBL] [Abstract][Full Text] [Related]
8. Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1.
O'Rourke JF; Pugh CW; Bartlett SM; Ratcliffe PJ
Eur J Biochem; 1996 Oct; 241(2):403-10. PubMed ID: 8917436
[TBL] [Abstract][Full Text] [Related]
9. Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells.
Ameri K; Lewis CE; Raida M; Sowter H; Hai T; Harris AL
Blood; 2004 Mar; 103(5):1876-82. PubMed ID: 14604972
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1alpha (HIF-1alpha) is a non-heme iron protein. Implications for oxygen sensing.
Srinivas V; Zhu X; Salceda S; Nakamura R; Caro J
J Biol Chem; 1998 Jul; 273(29):18019-22. PubMed ID: 9660756
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.
Jansová H; Bureš J; Macháček M; Hašková P; Jirkovská A; Roh J; Wang Q; Franz KJ; Kovaříková P; Šimůnek T
Toxicology; 2016 Mar; 350-352():15-24. PubMed ID: 27046792
[TBL] [Abstract][Full Text] [Related]
12. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
Kurz T; Gustafsson B; Brunk UT
FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.
An WG; Kanekal M; Simon MC; Maltepe E; Blagosklonny MV; Neckers LM
Nature; 1998 Mar; 392(6674):405-8. PubMed ID: 9537326
[TBL] [Abstract][Full Text] [Related]
14. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation.
Le NT; Richardson DR
Blood; 2004 Nov; 104(9):2967-75. PubMed ID: 15251988
[TBL] [Abstract][Full Text] [Related]
15. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
Meczynska S; Lewandowska H; Sochanowicz B; Sadlo J; Kruszewski M
Hemoglobin; 2008; 32(1-2):157-63. PubMed ID: 18274993
[TBL] [Abstract][Full Text] [Related]
16. Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation.
Wanner RM; Spielmann P; Stroka DM; Camenisch G; Camenisch I; Scheid A; Houck DR; Bauer C; Gassmann M; Wenger RH
Blood; 2000 Aug; 96(4):1558-65. PubMed ID: 10942406
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.
Potůčková E; Hrušková K; Bureš J; Kovaříková P; Špirková IA; Pravdíková K; Kolbabová L; Hergeselová T; Hašková P; Jansová H; Macháček M; Jirkovská A; Richardson V; Lane DJ; Kalinowski DS; Richardson DR; Vávrová K; Šimůnek T
PLoS One; 2014; 9(11):e112059. PubMed ID: 25393531
[TBL] [Abstract][Full Text] [Related]
18. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
Macková E; Hrušková K; Bendová P; Vávrová A; Jansová H; Hašková P; Kovaříková P; Vávrová K; Simůnek T
Chem Biol Interact; 2012 May; 197(2-3):69-79. PubMed ID: 22521999
[TBL] [Abstract][Full Text] [Related]
19. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
[TBL] [Abstract][Full Text] [Related]
20. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
Lim CK; Kalinowski DS; Richardson DR
Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
